2009
DOI: 10.1001/archoto.2009.70
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Outcomes of Postoperative Concurrent Chemoradiotherapy for Locally Advanced Major Salivary Gland Carcinoma

Abstract: Locally advanced or high-grade salivary gland carcinomas follow an aggressive clinical course. Based on our limited experience, postoperative chemoradiation with a platinum-based regimen seems to be effective in selected patients and warrants further investigation.

Search citation statements

Order By: Relevance

Paper Sections

Select...
69
36
9
0

Citation Types

0
77
1
2

Year Published

2009
2009
2026
2026

Publication Types

Select...
93
13
2
1

Relationship

2
107

Authors

Journals

citations

Cited by 109 publications

(80 citation statements)
references

References 17 publications

0
77
1
2
Order By: Relevance
How this paper cites the one you are viewing
“…This finding adds to a conflicting body of evidence on the effects of RT on pediatric salivary malignancies 18,20,40 . RT has a clear survival benefit in adult salivary malignancies with a variety of risk factors, and some evidence suggests that this benefit holds for pediatrics 5,41‐47 . Our findings of a survival benefit of adjuvant RT conflict with those of Radomski et al, 3 who found worse outcomes following the use of adjuvant RT.…”
Section: Discussion
contrasting
confidence: 57%
“…18,20,40 RT has a clear survival benefit in adult salivary malignancies with a variety of risk factors, and some evidence suggests that this benefit holds for pediatrics. 5,[41][42][43][44][45][46][47] Our findings of a survival benefit of adjuvant RT conflict with those of Radomski et al, 3 who found worse outcomes following the use of adjuvant RT. However, the authors did not control for a variety of critical factors in that analysis, including cancer stage and tumor grade.…”
Section: Discussion
mentioning
confidence: 60%
See 1 more Smart Citation
How this paper cites the one you are viewing
“…This finding adds to a conflicting body of evidence on the effects of RT on pediatric salivary malignancies 18,20,40 . RT has a clear survival benefit in adult salivary malignancies with a variety of risk factors, and some evidence suggests that this benefit holds for pediatrics 5,41‐47 . Our findings of a survival benefit of adjuvant RT conflict with those of Radomski et al, 3 who found worse outcomes following the use of adjuvant RT.…”
Section: Discussion
contrasting
confidence: 57%
“…18,20,40 RT has a clear survival benefit in adult salivary malignancies with a variety of risk factors, and some evidence suggests that this benefit holds for pediatrics. 5,[41][42][43][44][45][46][47] Our findings of a survival benefit of adjuvant RT conflict with those of Radomski et al, 3 who found worse outcomes following the use of adjuvant RT. However, the authors did not control for a variety of critical factors in that analysis, including cancer stage and tumor grade.…”
Section: Discussion
mentioning
confidence: 60%
How this paper cites the one you are viewing
“…A number of phase I and II trials have investigated systemic therapy with mixed results [16]. Recently, concurrent chemoradiation has been shown to improve LRC and PFS in retrospective series [7, 17, 18]. In our series, no statistically significant correlation was seen on either univariate or multivariate analysis perhaps due to the fact that only 39% of the patients received chemotherapy.…”
Section: Discussion
mentioning
confidence: 55%
How this paper cites the one you are viewing
“…A similar retrospective series with short follow-up included 12 high-risk patients receiving chemoradiation. They showed that the use of chemoradiation was associated with significantly better local control with no difference in overall survival compared to patients receiving RT alone[21]. Seven patients in our study received adjuvant chemoradiation.…”
Section: Discussion
mentioning
confidence: 70%